V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010664 | 270006279 | 1.72 | 85 | Curative (C) | 2017-06-18 | 2017-06-18 | CHOP | N | N | 270008586 | CAPECITABINE + CISPLATIN |
| 270010665 | 270006279 | 1.79 | 64 | Palliative (P) | null | 2017-06-19 | CETUXIMAB | 01 | N | 270008586 | CISPLATIN + FLUOROURACIL + RT |
| 270010666 | 270006280 | null | 81.75 | Neo-adjuvant (N) | 2017-06-24 | 2017-07-02 | CARBOPLATIN + GEMCITABINE | N | N | 270008676 | CETUXIMAB |
| 270010667 | 270006281 | 1.7 | 84 | Palliative (P) | 2016-07-13 | 2016-07-21 | CARBOPLATIN + RT | 02 | N | 270008724 | CARBOPLATIN + RT |
| 270010668 | 270006282 | 1.48 | 58 | Curative (C) | 2014-03-24 | 2014-03-24 | CETUXIMAB | 02 | N | 270008732 | CETUXIMAB |
| 270010669 | 270006283 | 1.51 | 66 | null | 2014-03-11 | 2014-03-30 | ChIVPP/EVA | N | N | 270008838 | ABVD R |
| 270010670 | 270006283 | 1.57 | 54.7 | Curative (C) | 2018-06-22 | 2018-06-22 | Raltitrexed | 02 | N | 270008838 | CAPECITABINE + IRINOTECAN |
| 270010671 | 270006284 | 1.63 | 66.1 | Palliative (P) | 2017-06-03 | 2017-06-04 | CHOP | 02 | N | 270008894 | VINBLASTINE |
| 270010672 | 270006285 | null | 46 | Disease modification (D) | 2015-07-19 | 2015-07-20 | CVP R | N | Y | 270008937 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 270010673 | 270006286 | null | 77.05 | Palliative (P) | 2017-02-10 | 2017-02-27 | Cisplatin + Etoposide (3 day) | N | N | 270009055 | CETUXIMAB + RT |
| 270010674 | 270006286 | 1.68 | 49.6 | Curative (C) | 2016-12-30 | 2016-12-30 | Cisplatin + Etoposide (3 day) | 02 | N | 270009055 | CETUXIMAB + RT |
| 270010675 | 270006286 | 1.55 | 49.6 | Curative (C) | 2017-10-15 | 2017-10-17 | CAP + RT | N | N | 270009055 | CETUXIMAB |
| 270010676 | 270006286 | 1.7 | null | Disease modification (D) | 2016-12-17 | 2016-12-22 | Enzalutamide | N | N | 270009055 | CETUXIMAB |
| 270010677 | 270018918 | 1.75 | 0 | Palliative (P) | 2015-02-20 | 2015-02-20 | Carboplatin AUC 2 - 5 | N | null | 270010140 | NOT MATCHED |
| 270010678 | 270018918 | 1.71 | null | null | 2013-08-17 | 2013-09-09 | ECX | N | N | 270010140 | CAP + RT |
| 270010679 | 270019826 | 1.57 | 52.3 | Curative (C) | null | 2017-10-18 | Mitomycin Intravesical | N | N | 270010206 | GEMCARBO |
| 270010680 | 270019826 | 1.64 | 67.95 | Palliative (P) | 2016-10-27 | 2016-11-01 | Cisplatin + Vinorelbine (PO) | 2 | N | 270010206 | CETUXIMAB + RT |
| 270010681 | 270006287 | 1.7 | 85 | Adjuvant (A) | 2017-07-24 | 2017-07-24 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270010424 | CARBOPLATIN + PEMETREXED |
| 270010682 | 270006287 | 1.69 | 65.7 | Palliative (P) | 2014-11-27 | 2014-11-30 | Cetuximab + Radiotherapy Load | Y | N | 270010424 | CARBOPLATIN + PEMETREXED |
| 270010683 | 270006287 | 1.6 | 69.7 | Curative (C) | 2015-01-31 | 2015-02-27 | ECX | N | Y | 270010424 | ABIRATERONE |
| 270010684 | 270017903 | 1.73 | 67.7 | Adjuvant (A) | 2017-05-14 | 2017-05-15 | CAP + RT | N | N | 270010596 | DOCETAXEL |
| 270010685 | 270017903 | 1.8 | 62.1 | Curative (C) | 2017-10-16 | 2017-10-16 | GEMCARBO | N | N | 270010596 | CETUXIMAB |
| 270010686 | 270006288 | null | null | Palliative (P) | 2015-04-29 | 2015-05-13 | null | N | N | 270010687 | RALTITREXED |
| 270010687 | 270006289 | null | 115 | Palliative (P) | null | 2016-08-27 | CISPLATIN + VINORELBINE | N | N | 270010721 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270010688 | 270006290 | 1.79 | 56.8 | Adjuvant (A) | 2016-06-14 | 2016-06-23 | CAPECITABINE + IRINOTECAN + RT | N | N | 270011308 | SCOT TRIAL |
| 270010689 | 270006291 | 1.77 | 70 | Adjuvant (A) | 2016-04-21 | 2016-04-22 | CARBOPLATIN + RT | 02 | N | 270011630 | CETUXIMAB + RT |
| 270010690 | 270006292 | 1.78 | null | Curative (C) | null | 2016-06-23 | GEMCITABINE | N | null | 270011809 | CARBOPLATIN |
| 270010691 | 270006293 | 1.68 | 88.7 | Palliative (P) | null | 2017-10-07 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270011886 | CISPLATIN + VINORELBINE + RT |
| 270010692 | 270006293 | 1.69 | null | Curative (C) | 2014-07-28 | 2014-08-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270011886 | CETUXIMAB |
| 270010693 | 270006294 | null | null | Curative (C) | 2016-07-25 | 2016-07-25 | Cytarabine Low Dose | N | N | 270011970 | ENZALUTAMIDE |
| 270010694 | 270006295 | 1.89 | 81 | Not known (9) | 2017-11-04 | 2017-11-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270011974 | CETUXIMAB + CISPLATIN + FU |
| 270010695 | 270006296 | 1.75 | 75 | Neo-adjuvant (N) | 2017-11-14 | 2017-11-21 | CETUXIMAB + RT | N | N | 270012127 | CARBOPLATIN + RT |
| 270010696 | 270006297 | 1.8 | 82.6 | Neo-adjuvant (N) | 2016-04-10 | 2016-04-24 | Cetuximab + FLUOROURACIL | 02 | N | 270012250 | CETUXIMAB |
| 270010697 | 270006298 | 1.83 | 98.6 | Not known (9) | 2018-01-20 | 2018-02-07 | Capecitabine (21days) + Carboplatin | null | null | 270012265 | CETUXIMAB + IRINOTECAN + MDG |
| 270010698 | 270006298 | 1.83 | 80 | Curative (C) | 2017-01-02 | 2017-01-04 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270012265 | ABVD R |
| 270010699 | 270006298 | null | 86.9 | Curative (C) | 2016-08-20 | 2016-08-20 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 270012265 | GEMCARBO |
| 270010700 | 270006298 | 1.73 | 66 | Curative (C) | 2018-07-14 | 2018-07-26 | Cetuximab 7 day (Cycle 1) | 2 | N | 270012265 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270010701 | 270006299 | 1.6 | 69.6 | Curative (C) | 2017-03-29 | 2017-03-29 | Cetuximab + Radiotherapy Load | N | null | 270013426 | CETUXIMAB + RT |
| 270010702 | 270013045 | 1.77 | null | Palliative (P) | 2017-09-01 | 2017-09-17 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270013472 | CISPLATIN + VINORELBINE + RT |
| 270010703 | 270013045 | 1.7 | 85 | Curative (C) | 2018-11-07 | 2018-11-12 | Capecitabine (14 days)+Carboplatin | 02 | N | 270013472 | CETUXIMAB + RT |
| 270010704 | 270006300 | 1.72 | 49 | Not known (9) | null | 2014-08-30 | Rituximab | N | null | 270013889 | CVP R |
| 270010705 | 270006301 | 1.76 | 70.6 | Not known (9) | 2016-10-30 | 2016-11-03 | CAP + RT | 2 | N | 270013929 | CARBOPLATIN |
| 270010706 | 270013046 | 1.61 | 63.6 | Palliative (P) | 2017-07-08 | 2017-07-08 | Azacitidine | N | N | 270014109 | PEMETREXED |
| 270010707 | 270006302 | 1.49 | 84.2 | Palliative (P) | 2017-08-25 | 2017-08-30 | CVP R | 2 | N | 270014128 | FCR |
| 270010708 | 270013047 | 1.58 | 55.3 | Curative (C) | null | 2017-11-15 | Cetuximab 14 day | N | Y | 270014345 | CETUXIMAB |
| 270010709 | 270016136 | null | 71.6 | Neo-adjuvant (N) | 2017-08-26 | 2017-09-01 | Cetuximab + FLUOROURACIL | N | N | 270014503 | CAPECITABINE + MITOMYCIN + RT |
| 270010710 | 270016136 | 1.81 | 82 | Curative (C) | 2014-07-05 | 2014-07-07 | Carboplatin + Vinorelbine Oral | N | N | 270014503 | GEMCARBO |
| 270010711 | 270006303 | 1.78 | 74.8 | Adjuvant (A) | 2018-06-25 | 2018-07-16 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 270014748 | CETUXIMAB + RT |
| 270010712 | 270006304 | 1.74 | 82 | Palliative (P) | 2013-10-30 | 2013-11-04 | CETUXIMAB + RT | 02 | N | 270014809 | ENZALUTAMIDE |
| 270010713 | 270006305 | null | null | Adjuvant (A) | 2017-11-03 | 2017-11-19 | Gemcitabine weekly | N | N | 270014838 | CETUXIMAB + IRINOTECAN + MDG |